Expression of truncated phosphoproteins of Nipah virus and Hendra virus in Escherichia coli for the differentiation of henipavirus infections.

The genus Henipavirus in the family Paramyxoviridae compromises two newly identified dangerous pathogens, Nipah virus and Hendra virus. Phosphoprotein of the two viruses is one of the major immunodominant antigens and the most divergent protein in the viral genomes. We have now expressed two pairs of truncated phosphoproteins of the two viruses in Escherichia coli in a soluble form using a vector tailored from pET32a. The truncated recombinant phosphoproteins were purified with His-Tag affinity chromatography and their antigenicity was determined by western blotting and ELISA. The longer pair of truncated recombinant phosphoproteins, covering amino acid residues 4-550, was more antigenic than the shorter one and of potential utility in the serological differentiation of henipavirus infections.
AuthorsJi-Ming Chen, Koon Chu Yaiw, Meng Yu, Lin-Fa Wang, Qing-Hua Wang, Gary Crameri, Zhi-Liang Wang
JournalBiotechnology letters (Biotechnol Lett) Vol. 29 Issue 6 Pg. 871-5 (Jun 2007) ISSN: 0141-5492 [Print] Netherlands
PMID17322967 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphoproteins
  • Recombinant Proteins
  • Viral Proteins
  • Blotting, Western
  • Enzyme-Linked Immunosorbent Assay
  • Escherichia coli (genetics, metabolism)
  • Gene Expression
  • Hendra Virus (genetics, metabolism)
  • Mutation
  • Nipah Virus (genetics, metabolism)
  • Phosphoproteins (genetics, immunology, metabolism)
  • Recombinant Proteins (genetics, immunology, metabolism)
  • Species Specificity
  • Viral Proteins (genetics, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: